Research & Technical Expertise
Advanced experimental and bioinformatic capabilities across cancer immunotherapy, adoptive T cell platforms, CRISPR gene editing, and biopharmaceutical antibody discovery.
T Cell Engineering & Immunotherapy
Developing TCR expression platforms in primary human T cells using lentiviral vectors and CRISPR/Cas9. Experienced in processing patient tumor specimens and expanding CD4+ & CD8+ cell cultures under aseptic conditions.
Learn MoreBioinformatics & Data Analytics
Building computational pipelines in Python & R for flow cytometry analysis, TCR-dextramer binding optimization, sequence analysis, and creating interactive scientific data products.
Learn MoreTherapeutic Antibody Discovery
Characterizing therapeutic antibody specificity and cross-reactivity using high-throughput Membrane Proteome Array (MPA) technology targeting membrane protein targets for biopharma clients.
Learn MoreCRISPR/Cas9 & Genome Editing
Targeted gene knockout and editing in human primary T cells, guide RNA design, delivery via lentiviral and ribonucleoprotein (RNP) complexes, and validation via PCR & sequencing.
Learn MoreMolecular Assays & Cell Culture
Extensive execution of standard, quantitative, and digital droplet PCR (qPCR/dPCR), Western Blotting, ELISA, gel electrophoresis, protein analysis, and aseptic viral production.
Learn MoreScientific Writing & Regulatory Support
Drafting comprehensive research reports for NIH-funded grant projects, internal regulatory documentation for cell therapies, and presenting research findings at national conferences.
Learn More